Search clinical trials for: Bortezomib (VELCADE)
Total 958 results
-
M.D. Anderson Cancer CenterCompleted
-
M.D. Anderson Cancer CenterCompletedLymphoma | Solid Tumors | Myeloma | Advanced MalignancyUnited States
-
M.D. Anderson Cancer CenterGenentech, Inc.; Millennium Pharmaceuticals, Inc.Withdrawn
-
AmgenCompletedMultiple MyelomaKorea, Republic of, Spain, Taiwan, Canada, Australia, Israel, Italy, United States, Singapore, New Zealand, Japan, Thailand, Brazil, United Kingdom, Hungary, Czechia, Romania, Slovakia, France, Germany, Russian Federation, Bulgaria, Belgiu... and more
-
University College, LondonCompletedWaldenstrom's MacroglobulinaemiaUnited Kingdom
-
Janssen Research & Development, LLCCompleted
-
PETHEMA FoundationJanssen-Cilag Ltd.; Mundipharma Pharmaceuticals B.V.Completed
-
Assistance Publique - Hôpitaux de ParisFondation CentaureCompletedChronic Antibody-mediated Transplant RejectionFrance
-
H. Lee Moffitt Cancer Center and Research InstituteMillennium Pharmaceuticals, Inc.CompletedMultiple Myeloma | Plasma Cell LeukemiaUnited States
-
UNC Lineberger Comprehensive Cancer CenterMerck Sharp & Dohme LLCWithdrawnStudy of Vorinostat With Doxil and Bortezomib for Patients With Relapsed/Refractory Multiple MyelomaMultiple MyelomaUnited States
-
Ida Bruun KristensenOdense Patient Data Explorative Network; Karyopharm Therapeutics IncActive, not recruitingMultiple MyelomaDenmark, Norway, Estonia
-
H. Lee Moffitt Cancer Center and Research InstituteJanssen Scientific Affairs, LLCActive, not recruitingMultiple MyelomaUnited States
-
Brown UniversityThe Miriam Hospital; Dartmouth-Hitchcock Medical Center; Rhode Island Hospital; Memorial Hospital of Rhode IslandTerminatedLymphoma, Non-HodgkinsUnited States
-
National Cancer Institute (NCI)TerminatedStage II Multiple Myeloma | Stage III Multiple Myeloma | Refractory Multiple MyelomaUnited States
-
Millennium Pharmaceuticals, Inc.CompletedMultiple MyelomaUnited States, Canada, Spain, Israel, United Kingdom, Germany, Austria, Belgium, France, Italy, Ireland, Netherlands, Sweden
-
Haukeland University HospitalUniversity of Oslo; Oslo University Hospital; University Hospital of North Norway and other collaboratorsRecruiting
-
Pharmacyclics Switzerland GmbHJanssen Research & Development, LLCCompletedMultiple MyelomaSpain, Germany, Turkey, Greece, Italy, Czechia
-
SCRI Development Innovations, LLCMillennium Pharmaceuticals, Inc.; CephalonCompleted
-
Janssen Research & Development, LLCCompleted
-
Janssen Research & Development, LLCCompletedMultiple MyelomaUnited States, France, Poland, United Kingdom, Belgium, Spain, Germany, Portugal, Bulgaria, Romania, Netherlands, Greece, Canada, Russian Federation, Hungary, Brazil, Slovakia, Czechia
-
Centocor, Inc.WithdrawnMultiple MyelomaCanada, United States, Belgium, Poland, Bulgaria, Turkey, Ukraine, Australia, Korea, Republic of, New Zealand, Czech Republic, United Kingdom, Netherlands, India
-
AB ScienceTerminatedMultiple MyelomaUnited States, France
-
Washington University School of MedicineMillennium Pharmaceuticals, Inc.CompletedMultiple MyelomaUnited States
-
Massachusetts General HospitalMillennium Pharmaceuticals, Inc.Completed
-
National Cancer Centre, SingaporeTerminatedExtranodal NK-T-CELL LYMPHOMASingapore
-
City of Hope Medical CenterNational Cancer Institute (NCI)CompletedRecurrent Mantle Cell Lymphoma | Stage III Mantle Cell Lymphoma | Stage IV Mantle Cell Lymphoma | Contiguous Stage II Mantle Cell Lymphoma | Noncontiguous Stage II Mantle Cell Lymphoma | Stage I Mantle Cell LymphomaUnited States
-
National Cancer Institute (NCI)CompletedAcute Myeloid Leukemia | Adult Acute Megakaryoblastic Leukemia (M7) | Adult Acute Minimally Differentiated Myeloid Leukemia (M0) | Adult Acute Monoblastic Leukemia (M5a) | Adult Acute Monocytic Leukemia (M5b) | Adult Acute Myeloblastic Leukemia With Maturation (M2) | Adult Acute Myeloblastic Leukemia... and other conditionsUnited States
-
Accelerated Community Oncology Research NetworkMillennium Pharmaceuticals, Inc.TerminatedMultiple MyelomaUnited States
-
Sun Yat-sen UniversityRecruitingMyeloma | Newly Diagnosed | High RiskChina
-
Barbara Ann Karmanos Cancer InstituteNational Cancer Institute (NCI)TerminatedPrimary Systemic Amyloidosis | Light Chain Deposition DiseaseUnited States, Canada
-
Canadian Myeloma Research GroupNot yet recruiting
-
Siddhartha GangulyCompleted
-
AEterna ZentarisCompletedMultiple Myeloma | Multiple Myeloma in Relapse
-
National Cancer Institute (NCI)CompletedHead and Neck CancerUnited States
-
Duke UniversityCompleted
-
National Cancer Institute (NCI)Completed
-
Millennium Pharmaceuticals, Inc.Johnson & Johnson Pharmaceutical Research & Development, L.L.C.CompletedMultiple Myeloma | Non-Hodgkin's LymphomaIsrael, Italy, Poland, South Africa, United Kingdom
-
AbbVieGenentech, Inc.CompletedRelapsed/Refractory Multiple MyelomaUnited States, Australia, Brazil, Canada, France, Germany, Hungary, Ireland, Italy, Japan, Korea, Republic of, Russian Federation, Spain, Taiwan, Ukraine, United Kingdom
-
Universitätsklinikum Hamburg-EppendorfCompleted
-
Janssen Pharmaceutical K.K.Completed
-
Dana-Farber Cancer InstituteBeth Israel Deaconess Medical Center; Millennium Pharmaceuticals, Inc.CompletedWaldenstrom's MacroglobulinemiaUnited States
-
Peking Union Medical College HospitalCompletedAutoimmune Hemolytic Anemia | Autoimmune Hemolytic Anemia and Autoimmune ThrombocytopeniaChina
-
NYU Langone HealthRecruiting
-
H. Lee Moffitt Cancer Center and Research InstituteMillennium Pharmaceuticals, Inc.CompletedMultiple MyelomaUnited States
-
Jennifer E. SchwartzMillennium Pharmaceuticals, Inc.CompletedGraft vs Host Disease | Peripheral Blood Stem Cell Transplantation | Transplantation, HomologousUnited States
-
Rush University Medical CenterGlaxoSmithKline; Millennium Pharmaceuticals, Inc.Terminated
-
Massachusetts General HospitalBayer; Dana-Farber Cancer Institute; Beth Israel Deaconess Medical Center; Brigham... and other collaboratorsCompletedMelanomaUnited States
-
National Cancer Institute (NCI)CompletedUnspecified Adult Solid Tumor, Protocol SpecificUnited States